Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 10 studies | 33% ± 18% | |
pericyte | 8 studies | 27% ± 5% | |
endothelial cell | 7 studies | 36% ± 15% | |
smooth muscle cell | 5 studies | 21% ± 5% | |
endothelial cell of lymphatic vessel | 3 studies | 20% ± 4% | |
endothelial cell of vascular tree | 3 studies | 25% ± 5% |
Insufficient scRNA-seq data for expression of MEOX2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3184.92 | 457 / 459 | 70% | 6.92 | 784 / 1118 |
lung | 94% | 1589.61 | 541 / 578 | 70% | 5.84 | 806 / 1155 |
thymus | 93% | 1101.28 | 609 / 653 | 66% | 4.29 | 401 / 605 |
skin | 70% | 645.86 | 1266 / 1809 | 46% | 20.91 | 216 / 472 |
bladder | 76% | 677.62 | 16 / 21 | 24% | 1.66 | 123 / 504 |
adipose | 99% | 4097.87 | 1186 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 2209.23 | 1262 / 1335 | 0% | 0 | 0 / 0 |
heart | 82% | 669.06 | 705 / 861 | 0% | 0 | 0 / 0 |
esophagus | 63% | 657.50 | 913 / 1445 | 17% | 1.07 | 31 / 183 |
uterus | 62% | 464.28 | 105 / 170 | 18% | 9.29 | 81 / 459 |
pancreas | 4% | 23.18 | 14 / 328 | 75% | 5.85 | 133 / 178 |
muscle | 70% | 553.94 | 564 / 803 | 0% | 0 | 0 / 0 |
intestine | 48% | 434.63 | 459 / 966 | 22% | 1.71 | 116 / 527 |
lymph node | 0% | 0 | 0 / 0 | 66% | 2.57 | 19 / 29 |
stomach | 23% | 191.36 | 82 / 359 | 34% | 3.40 | 96 / 286 |
prostate | 23% | 155.64 | 57 / 245 | 21% | 0.85 | 104 / 502 |
ovary | 25% | 182.66 | 45 / 180 | 15% | 1.15 | 63 / 430 |
tonsil | 0% | 0 | 0 / 0 | 36% | 1.54 | 16 / 45 |
brain | 0% | 1.81 | 8 / 2642 | 34% | 19.57 | 242 / 705 |
kidney | 1% | 5.33 | 1 / 89 | 30% | 4.07 | 270 / 901 |
liver | 1% | 5.33 | 3 / 226 | 19% | 1.01 | 78 / 406 |
adrenal gland | 3% | 23.53 | 8 / 258 | 17% | 1.02 | 38 / 230 |
spleen | 1% | 5.68 | 3 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090051 | Biological process | negative regulation of cell migration involved in sprouting angiogenesis |
GO_0001525 | Biological process | angiogenesis |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0061053 | Biological process | somite development |
GO_0060173 | Biological process | limb development |
GO_0001757 | Biological process | somite specification |
GO_0060021 | Biological process | roof of mouth development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016607 | Cellular component | nuclear speck |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MEOX2 |
Protein name | MEOX2 protein Homeobox protein MOX-2 (Growth arrest-specific homeobox) (Mesenchyme homeobox 2) |
Synonyms | GAX MOX2 |
Description | FUNCTION: Mesodermal transcription factor that plays a key role in somitogenesis and somitogenesis and limb muscle differentiation (By similarity). Required during limb development for normal appendicular muscle formation and for the normal regulation of myogenic genes (By similarity). May have a regulatory role when quiescent vascular smooth muscle cells reenter the cell cycle (By similarity). Also acts as a negative regulator of angiogenesis . Activates expression of CDKN1A and CDKN2A in endothelial cells, acting as a regulator of vascular cell proliferation . While it activates CDKN1A in a DNA-dependent manner, it activates CDKN2A in a DNA-independent manner . Together with TCF15, regulates transcription in heart endothelial cells to regulate fatty acid transport across heart endothelial cells (By similarity). . |
Accessions | ENST00000262041.6 P50222 Q6FHY5 |